These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28144834)

  • 1. Society for Health Psychology (APA Division 38) and Society of Behavioral Medicine joint position statement on the Medicare Diabetes Prevention Program.
    Fitzpatrick SL; Wilson DK; Pagoto SL;
    Transl Behav Med; 2017 Jun; 7(2):385-387. PubMed ID: 28144834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Society of Behavioral Medicine position statement on the CMS decision memo on intensive behavior therapy for obesity.
    Pagoto SL; Pbert L; Emmons K;
    Transl Behav Med; 2012 Dec; 2(4):381-3. PubMed ID: 24073141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Society of Behavioral Medicine (SBM) position statement: SBM urges Congress to preserve and extend funding for Medicaid services.
    Behrman P; Demirci J; Yanez B; Beharie N; Laroche H
    Transl Behav Med; 2019 Jan; 9(1):175-178. PubMed ID: 29741734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease.
    Chen F; Su W; Becker SH; Payne M; Castro Sweet CM; Peters AL; Dall TM
    PLoS One; 2016; 11(10):e0163627. PubMed ID: 27706216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.
    Kilian J; Stubbings J
    J Manag Care Pharm; 2007; 13(1):59-65. PubMed ID: 17269838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Identification and Referral of Adults With Prediabetes to a Diabetes Prevention Program.
    Holliday CS; Williams J; Salcedo V; Kandula NR
    Prev Chronic Dis; 2019 Jun; 16():E82. PubMed ID: 31255186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from Launching the Diabetes Prevention Program in a Large Integrated Health Care Delivery System: A Case Study.
    Rehm CD; Marquez ME; Spurrell-Huss E; Hollingsworth N; Parsons AS
    Popul Health Manag; 2017 Aug; 20(4):262-270. PubMed ID: 28075695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.
    Chambers JD; Chenoweth MD; Pyo J; Cangelosi MJ; Neumann PJ
    Int J Technol Assess Health Care; 2015 Jan; 31(5):347-54. PubMed ID: 26750558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value-based interventional pain management: a review of medicare national and local coverage determination policies.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Singh V; Hirsch JA
    Pain Physician; 2013; 16(3):E145-80. PubMed ID: 23703416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare Part D: how do vulnerable beneficiaries fare?
    Summer L; Nemore P; Finberg J
    Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare Part D-a roundtable discussion of current issues and trends.
    Balfour DC; Evans S; Januska J; Lee HY; Lewis SJ; Nolan SR; Noga M; Stemple C; Thapar K
    J Manag Care Pharm; 2009; 15(1 Suppl A):3-9. PubMed ID: 19125555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opacity and cost effectiveness analysis in Medicare coverage decisions: health policy encounters administrative law.
    Kolber MS
    Food Drug Law J; 2009; 64(3):515-30. PubMed ID: 19999645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal for a national coverage determination for the treatment of varicose veins and venous disease due to disparate Centers for Medicare and Medicaid Services local coverage determination policies.
    Welch HJ; Kabnick L; Vasquez MA; Monahan DL; Lurie F; Jacobowitz G
    J Vasc Surg Venous Lymphat Disord; 2017 May; 5(3):453-459. PubMed ID: 28411715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare, managed care, and behavioral health care.
    Rosenbaum S; Smith BM
    Issue Brief George Wash Univ Cent Health Serv Res Policy; 2000 Nov; (10):1-20. PubMed ID: 14982073
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.
    Depue R; Stubbings J
    J Manag Care Pharm; 2008; 14(1):50-60. PubMed ID: 18240882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program.
    Vojta D; Koehler TB; Longjohn M; Lever JA; Caputo NF
    Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S301-6. PubMed ID: 23498291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare program; ambulance services--HCFA. Proposed rule.
    Fed Regist; 1997 Jun; 62(116):32715-32. PubMed ID: 10169829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.